Management of HBV and HCV Patients
Chronic hepatitis B (CHB) and chronic hepatitis C (CHC) are serious viral diseases associated with significant and preventable morbidity and mortality. Asian-American communities bear a disproportionate burden of CHB and CHC, yet most remain undiagnosed and untreated and are therefore at significant risk for progression to advanced liver disease and premature death.
To help reverse this troubling trend, visit our series on ReachMD, which covers essential screening, testing, and treatment strategies for patients with CHB and CHC.
Program topics include:
Experts in chronic hepatitis B within Asian communities discuss prevention, screening and management options to reduce the number of new cases and the risk of progression to cirrhosis, hepatic failure, and hepatocellular carcinoma. Experts also will consider the integration of Western and Eastern Medicine approaches to treatment and how cultural perceptions and community stigmatization of persons of Asian descent with chronic HBV infection can create barriers to diagnosis and care.